EMA shortages Shortage ongoing Medicine shortages
Fludarabine — supply shortage (shortage ongoing)
Published by European Medicines Agency:
Summary
Supply shortage
Medicine
Fludarabine
- Category
- Medicine shortages
- Product type
- Human medicine
- Active substance (INN): fludarabine
- Therapeutic area: Leukemia
- Pharmaceutical forms affected: Concentrate for solution for injection/infusion
- Strengths affected: 25 mg/ml
- Expected resolution: The shortage is expected to last until December 2025.
- Last updated: 22/01/2026
Measures and alternatives
- Availability of alternatives: Unknown
Source: EMA — medicine shortages — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗